The conference will be covering topics as diverse as the dynamics of the omega-3 market in China.
Source: Global Organization for EPA and DHA Omega-3
SALT LAKE CITY (February 13, 2012) - The GOED Exchange 2012 conference opens registration this month with an exciting agenda for those involved in the omega-3 space. The conference will be covering topics as diverse as the dynamics of the omega-3 market in China, and how to communicate with consumers, and will also include an out-of-the box marketing challenges session that features the “Narrator-in-Chief” and emerging media strategist for the 2008 presidential campaign, Sam Graham-Felsen.
Hosted by the Global Organization for EPA and DHA (GOED), the GOED Exchange 2012 conference takes place at the Marriott Long Wharf Hotel in Boston, Massachusetts on June 6-8, 2012. The conference will feature a great mix of the latest scientific, marketing, regulatory and international perspectives that make the omega-3 business what it is today.
According to Adam Ismail, GOED Executive Director, “We are raising the bar, bringing together the highest caliber of speakers and panelists in the international omega-3 community.” The GOED Exchange goes beyond the basics of the omega-3 industry, said Ismail, “and is truly an interactive conference. The 2012 event promises to offer fresh perspectives as well as some old favorites from the inaugural Exchange.”
Specifically, the conference brings back the most popular sessions from the first GOED Exchange, including more founders of omega-3 research and innovative real-world uses of EPA and DHA. In addition, featured speaker Sam Graham-Felsen will talk about the challenges of marketing to millennials, traditionally a less engaged demographic for omega-3 usage. Additional speakers are being lined up to discuss how to combat negative marketing, and offer a true debate on safe intakes of omega-3s.
To see the full agenda and to register for the conference, visit www.goedexchange.com.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.